Detecting neutralization antibodies to covid 19Melvin Alex
A robust serological test to detect neutralizing antibodies to SARS Cov-2 is needed to determine not only the infection rate, herd immunity, and predicted humoral protection, but also vaccine efficacy during clinical trials after large-scale vaccination.
Lyme disease is caused by bacterium Borrelia burgdorferi. It is transmitted to humans through the bite of infected black-legged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans.
The Borrelia IgM ELISA kit is an indirect enzyme immunoassay for the qualitative or quantitative determination of Borrelia IgM antibodies in human serum, plasma, and CSF samples.
Detecting neutralization antibodies to covid 19Melvin Alex
A robust serological test to detect neutralizing antibodies to SARS Cov-2 is needed to determine not only the infection rate, herd immunity, and predicted humoral protection, but also vaccine efficacy during clinical trials after large-scale vaccination.
Lyme disease is caused by bacterium Borrelia burgdorferi. It is transmitted to humans through the bite of infected black-legged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans.
The Borrelia IgM ELISA kit is an indirect enzyme immunoassay for the qualitative or quantitative determination of Borrelia IgM antibodies in human serum, plasma, and CSF samples.
Poster prepared by Elise Schieck, Caroline Fossum, Bernt Hjertner and Claudia Lutzelschwab for the Virtual Livestock CRP Planning Meeting, 8-17 June 2020
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...John Blue
Natural Infection, Immunity & Prevalence of PCV2 - Dr. Michael Murtaugh and Dr. Cheryl Dvorak, University of Minnesota, USA , from the Boehringer Ingelheim Pre-AASV Conference, February 28, 2014 - Dallas, TX
More presentations at http://www.swinecast.com/2014-boehringer-ingelheim-aasv
The COVID-19 pandemic is driving the need for rapid development of effective vaccines and therapies. Developing an effective vaccine requires an understanding of the adaptive immune response to SARS-CoV-2. An assay to measure circulating antibodies, specifically neutralizing antibodies (NAbs) that disrupt receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2) binding to prevent SARS-COV-2 cell entry is an important research tool.
ImmunoRank is a high-throughput surrogate assay that semi-quantitative detects and ranks circulating SARS-CoV-2 neutralizing antibodies of all Ig classes (total antibody) in human plasma or serum. Highly correlated to FRNT or PRNT live virus tests, but is less laborious, takes only 80 minutes to complete, and does not require a BSL3 laboratory.
April 2014 - Antibodies Newsflash - BBI SolutionsBBISolutions
This month’s newsflash focuses on our recombinant Fab antibodies. Find out more about their clinical relevance and see new performance data for Cystatin C, Myeloperoxidase and C Reactive Protein recombinant Fab antibodies.
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
Dr. Tanja Opriessnig - Update on novel experimental pig vaccine approachesJohn Blue
Update on novel experimental pig vaccine approaches - Dr. Tanja Opriessnig, The Roslin Institute, University of Edinburgh and Iowa State University, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2016-north-american-prrs-symposium
Poster prepared by Elise Schieck, Caroline Fossum, Bernt Hjertner and Claudia Lutzelschwab for the Virtual Livestock CRP Planning Meeting, 8-17 June 2020
Dr. Michael Murtaugh and Dr. Cheryl Dvorak - Natural Infection, Immunity & Pr...John Blue
Natural Infection, Immunity & Prevalence of PCV2 - Dr. Michael Murtaugh and Dr. Cheryl Dvorak, University of Minnesota, USA , from the Boehringer Ingelheim Pre-AASV Conference, February 28, 2014 - Dallas, TX
More presentations at http://www.swinecast.com/2014-boehringer-ingelheim-aasv
The COVID-19 pandemic is driving the need for rapid development of effective vaccines and therapies. Developing an effective vaccine requires an understanding of the adaptive immune response to SARS-CoV-2. An assay to measure circulating antibodies, specifically neutralizing antibodies (NAbs) that disrupt receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2) binding to prevent SARS-COV-2 cell entry is an important research tool.
ImmunoRank is a high-throughput surrogate assay that semi-quantitative detects and ranks circulating SARS-CoV-2 neutralizing antibodies of all Ig classes (total antibody) in human plasma or serum. Highly correlated to FRNT or PRNT live virus tests, but is less laborious, takes only 80 minutes to complete, and does not require a BSL3 laboratory.
April 2014 - Antibodies Newsflash - BBI SolutionsBBISolutions
This month’s newsflash focuses on our recombinant Fab antibodies. Find out more about their clinical relevance and see new performance data for Cystatin C, Myeloperoxidase and C Reactive Protein recombinant Fab antibodies.
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
Dr. Tanja Opriessnig - Update on novel experimental pig vaccine approachesJohn Blue
Update on novel experimental pig vaccine approaches - Dr. Tanja Opriessnig, The Roslin Institute, University of Edinburgh and Iowa State University, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2016-north-american-prrs-symposium
Dr. Mike Roof - Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) ...John Blue
Impact of Porcine Reproductive & Respiratory Syndrome (PRRS) vaccination on infectious load and implications for area control and eradication - Dr. Mike Roof, Boehringer Ingelheim, from the 2016 North American PRRS Symposium, December 3‐4, 2016, Chicago, Illinois, USA.
More presentations at http://www.swinecast.com/2016-north-american-prrs-symposium
The purpose of this review is to provide veterinarians with key facts and information relevant to serological testing of individual dogs and cats in the clinical setting. Specifically, this paper addresses the role of antibody testing for the core, vaccine-preventable diseases canine distemper virus, canine and feline parvovirus, and canine adenovirus.
Automation in microbiology, changing concept and defeating challengesAyman Allam
A presentation about the automation in microbiology presented in 24th conference of the Egyptian Society of Medical Microbiology and immunology, 4/2017.
High Sensitivity HIV Testing and Translational Science around PrEPHopkinsCFAR
Joanne Stekler, MD MPH
Associate Professor, Department of Medicine
University of Washington
Inter-Center for AIDS ResearchAntiretroviralsfor Prevention Working Group
November 13, 2017
Katie Flanagan - Malaria vaccines current status and challengesWAidid
Vaccines are considered the most cost-effective means of control, prevention, elimination, eradication of infectious diseases: for this reason, a malaria vaccine would greatly assist in the drive to eradicate malaria from the world. Professor Flanagan presents in this slideset the current status and challenges of developing malaria vaccines.
To learn more, visit www.waidid.org!
Recent Advances in Immune Monitoring Presentation Slides Covance
The human immune system plays a pivotal role in conferring protective immunity to pathogenic microorganisms and cancer while its hyper-activation can result in serious inflammatory conditions such as autoimmunity. Immune monitoring is critical to determine the efficacy of therapeutic approaches such as the administration of a vaccine or to ascertain the safety of an administered agent such as a biologic that targets the immune system. Immune monitoring can involve the measurement of soluble immune mediators including cytokines and chemokines, as well as the analysis of phenotypic and functional status of immune cells. There is a plethora of platforms that offer highly sensitive and specific assays to monitor the immune system. These include simple immunoassays to complex multiplex assays that measure soluble biomarkers in various biological fluids and cell-based assays using a variety of platforms such as flow cytometry and enzyme-linked immunospot (ELISPOT) assay. In order to generate reliable immune monitoring data that will help us determine the safety and efficacy of the therapeutic intervention approach from a global study, highly standardized methods to collect, process and prepare patient samples need to be implemented. These slides focus on the recent advances in immune monitoring.
Antibody Testing in Clinical Practice - Indications for Point-of-Care TestingBiogal
This manuscript addresses the practical aspects of antibody testing for vaccine-preventable disease in clinical practice. The presentation focuses on the 2 most important factors surrounding the use of this technology: 1) the INDICATIONS for testing individual patients, and 2) Results-centered PATIENT MANAGEMENT (ie, what actions are indicated in the patient with a POSITIVE vs. NEGATIVE test result?)
Similar to The Immunobiology of Oil-in-Water Adjuvants for Influenza Vaccines (20)
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
CDSCO and Phamacovigilance {Regulatory body in India}
The Immunobiology of Oil-in-Water Adjuvants for Influenza Vaccines
1. The Immunobiology of Oil-in-Water Adjuvants for Influenza Vaccines Karen K. Yam, Ph.D. Post-doctoral Fellow (Brian Ward Lab) PCIRN Annual Meeting Wednesday April 20th, 2011
2. Objectives Understand the influence of adjuvants on long-term humoral responses to influenza following vaccination PCIRN RT-03 Study Canadian pH1N1 influenza vaccine ASO3 adjuvant 25% of the antigen dose of regular vaccine Hypothesis Low dose of antigen in adjuvanted vaccine may enhance the short-term response at the expense of the long-term immunity
4. Methods:Sample selection RT-03 serum samples in the PCIRN archive Selected: All 3 timepoints available V1, V2, V3 73 subjects selected
5. Methods:Serum Analysis Hemagglutination Inhibition (HAI) assay Titer of flu-specific Abs National Microbiology Laboratory Micro-neutralization (MN) assay Titer of functional Abs that can neutralize viral entry Avidity Index ELISA Measure of the binding strength of flu-specific Ab Read-out for the development of humoralimmresp
7. Affinity/Avidity Maturation B B B B ag ag ag ag ag ag ag ag B B B High affinity Avidity Index (AI) Quantify strength of Ab binding Concentration of urea required to displace 50% of flu-specific Abs B Low affinity
9. HAI Naive/Primedsubjects GMT Primed subjects with HAI >10 at V1 Naive = 55/73 (75%) Primed = 18/73 (25%) MN GMT Avidity Avidity Index
10.
11.
12.
13.
14.
Editor's Notes
The Immunobiology of Oil-in-Water Adjuvants for Influenza Vaccines
My objective...This will be done in the context of the PCIRN RT-03 StudySubjects were given the Canadian pandemic H1N1 influenza vaccine...And essentially, our hypothesis is that...
STUDY RESULTSEpub Dec 2010The RT-03 was completed between November 2009 and January 2010(Pediatric) study showed that one pediatric dose of adjuvanted pH1N1 vaccine elicited potentially protective titers (≥ 40) in 80% of seronegative children while a second dose raised this to 100% and increased GMT by 10-fold. Naturally primed children had strong responses; such high titers may afford greater or longer-lasting protection.
Geometric mean with 95% confidence intervalof HAI, MN, Avidity ELISAs